YASIR B ELAMIN
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry RESTON, VA NPI 1003945346
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry VA Vanda Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$2,854.42
- Category: General Payments
- Program years: PY2018–2024
- Record count: 121
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $208.76 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $208.76 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $119.90 | 4 |
| ABBVIE INC. | $88.86 | 4 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1103683863 | ABBVIE INC. | $28.76 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103683865 | ABBVIE INC. | $19.65 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103683867 | ABBVIE INC. | $26.44 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103683869 | ABBVIE INC. | $14.01 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133901815 | Vanda Pharmaceuticals Inc. | $29.02 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133901817 | Vanda Pharmaceuticals Inc. | $32.11 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133901819 | Vanda Pharmaceuticals Inc. | $33.22 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133901821 | Vanda Pharmaceuticals Inc. | $25.55 | 11/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.